The first FDA-approved drug to slow the decline of Alzheimer’s was approved today, and the University of Alabama at Birmingham has been involved in clinical trials of the drug for five years. We talked to Alzheimer’s researchers and advocates at UAB to learn more.
Ever wonder what happens to that vial of blood that is taken at your doctor’s office? UAB employees were once analyzing up to 5,000 vials of blood each night of the week. But, the testing process has just gotten a huge technology infusion from UAB.
UAB Medicine recently welcomed their new automated hospital laboratory.